Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corcept Therapeutics Inc | CORT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 22.48 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 22.48 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 20.84 - 34.275 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 22.48 | USD |
Corcept Therapeutics (CORT) Options Flow Summary
Corcept Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.33B | 103.52M | - | 482.38M | 106.14M | 1.03 | 21.93 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corcept Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CORT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 22.87 | 24.23 | 20.84 | 22.58 | 1,753,365 | -0.39 | -1.71% |
| 1 Month | 25.43 | 26.10 | 20.84 | 23.64 | 1,030,071 | -2.95 | -11.60% |
| 3 Months | 21.31 | 26.10 | 20.84 | 23.41 | 1,104,397 | 1.17 | 5.49% |
| 6 Months | 28.04 | 33.28 | 20.84 | 24.55 | 1,207,399 | -5.56 | -19.83% |
| 1 Year | 22.42 | 34.275 | 20.84 | 25.42 | 934,336 | 0.06 | 0.27% |
| 3 Years | 24.15 | 34.275 | 15.825 | 23.15 | 872,177 | -1.67 | -6.92% |
| 5 Years | 12.26 | 34.275 | 9.55 | 20.18 | 960,037 | 10.22 | 83.36% |
Corcept Therapeutics Description
| Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. |
